Top 5 Future Oncology articles – July 2021

Written by Louis Gautier, Future Science Group

Editor's highlights from Future Oncology

In this latest instalment of his regular monthly column, Louis Gautier, Commissioning Editor of Future Oncology, exclusively shares his top 5 peer-reviewed articles from the recent journal issues, which we have made freely available for you, Oncology Central members! Check out Louis’ highlights below. The management of patients with difficult-to-treat multiple myeloma  Initial treatment for multiple myeloma is largely based on the fitness of patients and focuses on decreasing the circulating monoclonal plasma cell count, with remission feasible after high-dose chemotherapy and stem cell transplant. However, minimal residual disease has proved challenging to clear completely, making multiple relapses common. Patients can also become refractory to multiple lines of therapy and...

To view this content, please register now for access

It's completely free